• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

hZnT-4在人前列腺组织中的差异表达。

Differential expression of hZnT-4 in human prostate tissues.

作者信息

Beck Frances W J, Prasad Ananda S, Butler Charles E, Sakr Wael A, Kucuk Omer, Sarkar Fazlul H

机构信息

Department of Internal Medicine, Division of Hematology/Oncology and Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

出版信息

Prostate. 2004 Mar 1;58(4):374-81. doi: 10.1002/pros.10344.

DOI:10.1002/pros.10344
PMID:14968438
Abstract

BACKGROUND

Altered zinc levels in prostate benign prostatic hyperplasia (BPH) and carcinoma is well documented. It is not known whether loss of zinc, necessary to restrain aggressive growth, results from loss of a single specific or multiple zinc transporters.

METHODS

Human prostate tissues from patients who underwent radical prostatectomy were screened by RT-PCR analysis for five zinc transporters. Relative cDNA expression was determined in normal, BPH, and tumor specimens and four prostate epithelial cell lines.

RESULTS

Surgical specimens were obtained from patients with assigned Gleason scores ranging from 5 to 9. Relative expression of hZIP-1 and hZnT-1 were prominent in most samples with relatively lesser degree of expression of hZIP-2 and no detectable expression of hZnT-3. Expression of hZnT-4 was decreased in BPH and tumor samples compared to normal tissue.

CONCLUSIONS

These data suggest that zinc homeostasis in normal prostate tissues results from an interplay of multiple transporters and decreased hZnT-4 expression is associated with prostate tissue abnormalities independent of total cellular zinc content.

摘要

背景

前列腺良性前列腺增生(BPH)和癌组织中锌水平的改变已有充分记录。目前尚不清楚抑制侵袭性生长所需的锌的丢失是由单一特定锌转运蛋白的丢失还是多种锌转运蛋白的丢失导致的。

方法

对接受根治性前列腺切除术患者的人前列腺组织进行逆转录聚合酶链反应(RT-PCR)分析,以检测五种锌转运蛋白。在正常、BPH和肿瘤标本以及四种前列腺上皮细胞系中测定相对cDNA表达。

结果

手术标本取自Gleason评分在5至9之间的患者。hZIP-1和hZnT-1的相对表达在大多数样本中较为突出,hZIP-2的表达程度相对较低,且未检测到hZnT-3的表达。与正常组织相比,BPH和肿瘤样本中hZnT-4的表达降低。

结论

这些数据表明,正常前列腺组织中的锌稳态是由多种转运蛋白相互作用产生的,hZnT-4表达降低与前列腺组织异常有关,且与细胞总锌含量无关。

相似文献

1
Differential expression of hZnT-4 in human prostate tissues.hZnT-4在人前列腺组织中的差异表达。
Prostate. 2004 Mar 1;58(4):374-81. doi: 10.1002/pros.10344.
2
Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.人前列腺组织和细胞中CD10/中性内肽酶24.11基因的细胞特异性表达。
Prostate. 2004 Mar 1;58(4):394-405. doi: 10.1002/pros.10345.
3
Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9.白细胞亚群中的细胞内锌稳态由锌转运体ZnT-1至ZnT-9的不同表达调控。
J Leukoc Biol. 2008 Feb;83(2):368-80. doi: 10.1189/jlb.0307148. Epub 2007 Oct 30.
4
Increased expression of NKX3.1 in benign prostatic hyperplasia.NKX3.1在良性前列腺增生中的表达增加。
Urology. 2009 May;73(5):1140-4. doi: 10.1016/j.urology.2008.02.039. Epub 2008 Jul 2.
5
Expression of ZnT and ZIP zinc transporters in the human RPE and their regulation by neurotrophic factors.锌转运体ZnT和ZIP在人视网膜色素上皮中的表达及其受神经营养因子的调控
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1221-31. doi: 10.1167/iovs.07-0781.
6
FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.成纤维细胞生长因子17是一种自分泌前列腺上皮生长因子,在良性前列腺增生中上调。
Prostate. 2004 Jun 15;60(1):18-24. doi: 10.1002/pros.20026.
7
Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line.锌转运体mRNA在RWPE - 1人前列腺上皮细胞系中的表达。
Biometals. 2008 Aug;21(4):405-16. doi: 10.1007/s10534-007-9129-0. Epub 2007 Dec 21.
8
Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.RECK表达降低表明前列腺癌中蛋白水解失衡,这与更高的肿瘤侵袭性以及根治性前列腺切除术后前列腺特异性抗原复发风险相关。
Eur Urol. 2007 May;51(5):1259-66. doi: 10.1016/j.eururo.2006.05.050. Epub 2006 Jun 14.
9
Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.人前列腺上皮细胞中分化抑制因子(Id)基因表达及功能的非冗余性
Prostate. 2006 Jun 15;66(9):921-35. doi: 10.1002/pros.20366.
10
Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.激光显微切割前列腺癌组织中雌激素受体基因表达的定量逆转录聚合酶链反应分析
Prostate. 2009 Jun 1;69(8):810-9. doi: 10.1002/pros.20929.

引用本文的文献

1
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.细胞锌代谢和锌信号转导:从生物学功能到疾病和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):6. doi: 10.1038/s41392-023-01679-y.
2
The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells.ZnT1 和 ZnT4 在前列腺上皮细胞葡萄糖刺激锌分泌中的作用。
Mol Imaging Biol. 2021 Apr;23(2):230-240. doi: 10.1007/s11307-020-01557-x. Epub 2020 Nov 2.
3
Recapitulation of prostate tissue cell type-specific transcriptomes by an in vivo primary prostate tissue xenograft model.
体内原代前列腺组织异种移植模型对前列腺组织细胞类型特异性转录组的概述。
PLoS One. 2020 Jun 25;15(6):e0233899. doi: 10.1371/journal.pone.0233899. eCollection 2020.
4
Advances of Zinc Signaling Studies in Prostate Cancer.锌信号在前列腺癌研究中的进展。
Int J Mol Sci. 2020 Jan 19;21(2):667. doi: 10.3390/ijms21020667.
5
Oyster-Derived Zinc-Binding Peptide Modified by Plastein Reaction via Zinc Chelation Promotes the Intestinal Absorption of Zinc.牡蛎来源的锌结合肽通过锌螯合的类蛋白反应修饰促进锌的肠道吸收。
Mar Drugs. 2019 Jun 8;17(6):341. doi: 10.3390/md17060341.
6
Resveratrol-zinc combination for prostate cancer management.白藜芦醇-锌联合用于前列腺癌治疗
Cell Cycle. 2014;13(12):1867-74. doi: 10.4161/cc.29334. Epub 2014 May 27.
7
Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.成年非增生性前列腺腺体中与年龄相关的组织学和锌含量变化。
Age (Dordr). 2014 Feb;36(1):167-81. doi: 10.1007/s11357-013-9561-8. Epub 2013 Jul 14.
8
Zinc transporters in prostate cancer.前列腺癌中的锌转运体。
Mol Aspects Med. 2013 Apr-Jun;34(2-3):735-41. doi: 10.1016/j.mam.2012.11.007.
9
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy.MI-219-锌复合物:基于 MDM2 抑制剂的治疗的新范例。
Oncogene. 2011 Jan 6;30(1):117-26. doi: 10.1038/onc.2010.403. Epub 2010 Sep 6.
10
Dietary zinc and prostate cancer in the TRAMP mouse model.饮食中的锌与 TRAMP 小鼠模型中的前列腺癌。
J Med Food. 2010 Feb;13(1):70-6. doi: 10.1089/jmf.2009.0042.